258 related articles for article (PubMed ID: 10874668)
21. Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations.
Gurzu S; Jung I
Pathol Res Pract; 2012 Mar; 208(3):163-6. PubMed ID: 22361037
[TBL] [Abstract][Full Text] [Related]
22. Expression of cytokeratins in gliomas.
Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
[TBL] [Abstract][Full Text] [Related]
23. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
[TBL] [Abstract][Full Text] [Related]
24. Pathological and immunohistochemical studies of choroid plexus carcinoma of the dog.
Cantile C; Campani D; Menicagli M; Arispici M
J Comp Pathol; 2002; 126(2-3):183-93. PubMed ID: 11945007
[TBL] [Abstract][Full Text] [Related]
25. Expression of EAAT-1 distinguishes choroid plexus tumors from normal and reactive choroid plexus epithelium.
Beschorner R; Pantazis G; Jeibmann A; Boy J; Meyermann R; Mittelbronn M; Schittenhelm J
Acta Neuropathol; 2009 Jun; 117(6):667-75. PubMed ID: 19283393
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic markers in the histopathological diagnosis of tumors of the choroid plexus].
Varga Z; Vajtai I
Orv Hetil; 1998 Mar; 139(13):761-5. PubMed ID: 9578705
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
[TBL] [Abstract][Full Text] [Related]
28. Coexpression of cytokeratins 7 and 20 confirms urothelial carcinoma presenting as an intrarenal tumor.
Han AC; Duszak R
Cancer; 1999 Dec; 86(11):2327-30. PubMed ID: 10590374
[TBL] [Abstract][Full Text] [Related]
29. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
Groisman GM; Meir A; Sabo E
Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551
[TBL] [Abstract][Full Text] [Related]
30. Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen.
DeCostanzo DC; Elias JM; Chumas JC
Int J Gynecol Pathol; 1997 Jul; 16(3):245-9. PubMed ID: 9421090
[TBL] [Abstract][Full Text] [Related]
31. Choroid plexus tumours--an immunohistochemical analysis with review of literature.
Radotra BD; Joshi K; Kak VK; Banerjee AK
Indian J Pathol Microbiol; 1994 Jan; 37(1):9-19. PubMed ID: 7522222
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic value of cytokeratins expression in the renal parenchyma tumors.
Alexa A; Baderca F; Lighezan R; Izvernariu D; Raica M
Rom J Morphol Embryol; 2010; 51(1):27-35. PubMed ID: 20191116
[TBL] [Abstract][Full Text] [Related]
33. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
Tot T
Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262
[TBL] [Abstract][Full Text] [Related]
34. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
Al-Zahrani IH
Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
[TBL] [Abstract][Full Text] [Related]
35. A case series and immunophenotypic analysis of CK20-/CK7+ primary neuroendocrine carcinoma of the skin.
Calder KB; Coplowitz S; Schlauder S; Morgan MB
J Cutan Pathol; 2007 Dec; 34(12):918-23. PubMed ID: 18001414
[TBL] [Abstract][Full Text] [Related]
36. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
[TBL] [Abstract][Full Text] [Related]
37. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
Tot T
Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
[TBL] [Abstract][Full Text] [Related]
38. Tubular carcinoids of the appendix: the CK7/CK20 immunophenotype can be a diagnostic pitfall.
Matsukuma KE; Montgomery EA
J Clin Pathol; 2012 Jul; 65(7):666-8. PubMed ID: 22461652
[TBL] [Abstract][Full Text] [Related]
39. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV
Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517
[TBL] [Abstract][Full Text] [Related]
40. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
Chu P; Wu E; Weiss LM
Mod Pathol; 2000 Sep; 13(9):962-72. PubMed ID: 11007036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]